Study guide
11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems
Key Takeaways Explain This Topic AI
In Mapleson systems ('All Dogs Can Bite'), Mapleson A is most gas-efficient for spontaneous breathing requiring fresh gas flows of 0.7-1.0 times minute volume, whereas Mapleson D is most efficient for controlled ventilation requiring 1.5-2.0 times minute volume.
The circle system prevents rebreathing via competent unidirectional valves and absorbs carbon dioxide via an exothermic neutralization reaction in soda lime ( C a ( O H ) 2 + C O 2 → C a C O 3 + H 2 O + heat Ca(OH)_2 + CO_2 \rightarrow CaCO_3 + H_2O + \text{heat} C a ( O H ) 2 + C O 2 → C a C O 3 + H 2 O + heat ).
Desiccated strong-base absorbents ( K O H / N a O H KOH/NaOH K O H / N a O H ) degrade volatile anaesthetics into dangerous toxins: sevoflurane produces nephrotoxic Compound A under low flows, whereas desflurane produces lethal carbon monoxide.
Variable-bypass vaporizers use bimetallic temperature compensation strips to maintain stable output despite evaporative cooling, whereas the Tec 6 for desflurane is electrically heated to 39°C to create 200 kPa vapour pressure.
The Tec 6 desflurane vaporizer delivers a constant volume percentage rather than a constant partial pressure, requiring dial settings to be increased at high altitudes to deliver equivalent depth of anaesthesia.
Last updated: October 2026
11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems
Anaesthetic breathing systems deliver fresh gases and inhaled anaesthetics from the workstation to the patient's airway while removing exhaled carbon dioxide. Selecting the optimal breathing circuit and understanding carbon dioxide absorption chemistry, vaporizer thermodynamics, and scavenging systems are core competencies in anaesthetic physics.
Classification of Breathing Systems: The Mapleson Hierarchy
In 1954, W.W. Mapleson categorized semi-closed breathing systems into types A through E based on the relative spatial arrangements of three primary components: the Fresh Gas Flow (FGF) inlet , the Adjustable Pressure-Limiting (APL) spill valve , and the Reservoir Bag . In 1975, Willis added the Jackson-Rees modification as Mapleson F.
The Efficiency Mnemonic: "All Dogs Can Bite"
To memorize the relative gas efficiency (lowest required FGF to prevent rebreathing of carbon dioxide):
Spontaneous Ventilation: A > D > F = E > C > B ( "All Dogs Feel Every Cold Breeze" or "A is best for Awake" )
Controlled Mechanical Ventilation: D > F = E > B > C > A ( "Dogs Can Bite All" or "D is best for Dead / sedated" )
Detailed Mapleson Circuit Mechanics Mapleson A (Magill): [FGF] ====== (Reservoir Bag) ====== [Corrugated Limb] ====== [APL Valve] --- (Patient)
- Mapleson D (Bain): [Machine End: Bag & APL] ====== [Outer Tube / Inner FGF Tube] ====== (Patient)
- Mapleson E (Ayre's): [Machine End: Open Tube] ====== [T-Piece with FGF] ====== (Patient)
- Mapleson F (J-Rees): [Open-tail Bag] ====== [Expiratory Limb with T-Piece FGF] ====== (Patient)
- 1. Mapleson A (Magill and Lack Systems)
Configuration: Fresh gas enters at the machine end near the reservoir bag; the APL valve is positioned at the patient end of the corrugated tubing.
Spontaneous Ventilation Mechanics: During exhalation, the first gas leaving the patient is anatomical dead space gas (which contains 100 % 100\% 100% fresh gas, high O 2 O_2 O 2 , zero C O 2 CO_2 C O 2 ). This dead space gas travels back up the corrugated tubing into the reservoir bag. As exhalation continues, alveolar gas ( C O 2 CO_2 C O 2 -rich) enters the tubing; simultaneously, pressure in the system rises, opening the APL valve near the patient and venting the late alveolar gas to the scavenging system. During the next inspiration, the patient inhales the unvitiated dead space gas stored in the tubing, followed by incoming fresh gas.
Spontaneous Efficiency: Most efficient system for spontaneous breathing . Requires an FGF equal to only 0.7 to 1.0 × minute volume (MV) 0.7\text{ to }1.0 \times \text{minute volume (MV)} 0.7 to 1.0 × minute volume (MV) to prevent rebreathing.
Controlled Ventilation Mechanics: Completely inefficient. When the anaesthetist squeezes the bag during positive-pressure inspiration, the APL valve opens under pressure, dumping fresh gas out into the scavenger before it reaches the patient. During expiration, alveolar gas enters the corrugated limb. Preventing rebreathing during controlled ventilation requires astronomical flows ( > 2.5 − 3.0 × M V >2.5-3.0 \times MV > 2.5 − 3.0 × M V ).
The Lack System: A coaxial version of Mapleson A where the APL valve is relocated to the machine end via an internal expiratory tube, avoiding heavy valves near the patient's face.
2. Mapleson D and the Bain Coaxial Circuit
Configuration: Fresh gas enters at the patient connector; the APL valve and reservoir bag are situated at the distal machine end.
The Bain Circuit: A coaxial Mapleson D where fresh gas travels through a narrow internal tube ( 7 mm 7\text{ mm} 7 mm ), while expired gas flows through the outer corrugated transparent tube ( 22 mm 22\text{ mm} 22 mm ) to the bag and APL valve.
Controlled Ventilation Mechanics: Most efficient system for controlled ventilation . During expiration, continuous high-flow fresh gas delivered directly at the patient connector flushes exhaled alveolar gas down the outer corrugated tube away from the patient toward the machine-end APL valve and bag. During mechanical inspiration, the patient receives incoming fresh gas mixed with gas from the outer limb. Required FGF to maintain normocarbia is only 1.5 to 2.0 × M V 1.5\text{ to }2.0 \times MV 1.5 to 2.0 × M V (or 70 − 100 mL/kg/min 70-100\text{ mL/kg/min} 70 − 100 mL/kg/min ).
Spontaneous Ventilation Mechanics: Requires high fresh gas flows of 2.5 to 3.0 × M V 2.5\text{ to }3.0 \times MV 2.5 to 3.0 × M V because during exhalation, alveolar gas mixes with fresh gas in the outer tube and must be washed out by pure flow volume.
Bain Circuit Hazard and the Pethick Test: If the inner fresh gas tube becomes disconnected or cracked at the machine end, fresh gas never reaches the patient port; instead, the entire length of the outer tube becomes massive mechanical dead space, producing catastrophic, lethal hypercapnia without any external leak. The Pethick Test: Occlude the patient end of the circuit with a thumb and depress the oxygen flush valve while observing the reservoir bag. The high-speed flow through the intact inner tube creates a Venturi effect that draws gas out of the outer tube, causing the reservoir bag to collapse flat . If the inner tube is disconnected or torn, the bag inflates or remains distended.
3. Mapleson E (Ayre's T-Piece) and Mapleson F (Jackson-Rees Modification)
Configuration: Valveless circuits with an open expiratory limb (Mapleson E) or an open-ended reservoir bag with an adjustable tail-bleed valve (Mapleson F).
Paediatric Advantages: Because there are no internal valves and no heavy corrugated hoses, these circuits exert extremely low resistance to breathing and minimal mechanical dead space, making them ideal for neonates and infants weighing < 20 kg <20\text{ kg} < 20 kg .
Fresh Gas Requirements: Valveless design means ambient air can be entrained if flow is inadequate; requires high flows of 2.5 to 3.0 × M V 2.5\text{ to }3.0 \times MV 2.5 to 3.0 × M V to prevent rebreathing.
The Circle System: Components and Carbon Dioxide Absorption Chemistry
The Circle System is the standard breathing system in modern anaesthetic workstations. It allows complete rebreathing of expired gases after chemical absorption of carbon dioxide, enabling low-flow anaesthesia ( F G F < 1 L/min FGF < 1\text{ L/min} FGF < 1 L/min ) and closed-circuit techniques.
- Components of the Circle System
- Fresh gas inlet (downstream of absorber, upstream of inspiratory valve)
- Unidirectional inspiratory valve
- Corrugated inspiratory breathing hose
- Patient Y-piece (the only point of mechanical dead space in the circuit!)
- Corrugated expiratory breathing hose
- Unidirectional expiratory valve
- Adjustable pressure-limiting (APL) valve / ventilator spill valve
- Reservoir bag / mechanical ventilator bellows
- Carbon dioxide absorption canister
Safety Feature: The unidirectional valves (lightweight mica, plastic, or ceramic discs) ensure that gas flows in one direction only. If an expiratory or inspiratory valve warps or sticks open with moisture, gas moves bidirectionally, converting the entire corrugated limb into mechanical dead space. This results in immediate rebreathing of C O 2 CO_2 C O 2 , diagnosed on capnography by an elevated Phase I baseline ( > 0 mmHg >0\text{ mmHg} > 0 mmHg ) .
Carbon Dioxide Absorption Chemistry: Soda Lime
Soda lime absorbs C O 2 CO_2 C O 2 through an exothermic acid-base neutralization cascade.
Composition:
Calcium Hydroxide ( C a ( O H ) 2 Ca(OH)_2 C a ( O H ) 2 ): 76 − 80 % 76-80\% 76 − 80% (the primary absorbing substrate)
Water ( H 2 O H_2O H 2 O ): 13 − 19 % 13-19\% 13 − 19% (critical; moisture dissolves gaseous C O 2 CO_2 C O 2 into carbonic acid)
- Sodium Hydroxide ( N a O H NaOH N a O H ): 3 − 4 % 3-4\% 3 − 4% (catalytic strong-base activator)
- Potassium Hydroxide ( K O H KOH K O H ): 1 % 1\% 1% (omitted in modern formulations due to toxicity)
- Silica / Kieselguhr: 0.2 % 0.2\% 0.2% (added for granule hardness to prevent caustic dust formation)
- The Chemical Neutralization Cascade
Gaseous C O 2 CO_2 C O 2 dissolves in the thin aqueous film on the granules to form carbonic acid: C O 2 + H 2 O ⇌ H 2 C O 3 CO_2 + H_2O \rightleftharpoons H_2CO_3 C O 2 + H 2 O ⇌ H 2 C O 3
Carbonic acid reacts rapidly with the strong-base catalyst ( N a O H NaOH N a O H ) in an exothermic neutralization: H 2 C O 3 + 2 N a O H → N a 2 C O 3 + 2 H 2 O + heat H_2CO_3 + 2NaOH \rightarrow Na_2CO_3 + 2H_2O + \text{heat} H 2 C O 3 + 2 N a O H → N a 2 C O 3 + 2 H 2 O + heat
Sodium carbonate reacts with calcium hydroxide to precipitate insoluble calcium carbonate, regenerating the catalyst: N a 2 C O 3 + C a ( O H ) 2 → C a C O 3 ↓ + 2 N a O H Na_2CO_3 + Ca(OH)_2 \rightarrow CaCO_3\downarrow + 2NaOH N a 2 C O 3 + C a ( O H ) 2 → C a C O 3 ↓ + 2 N a O H
Heat and Moisture Generation: Neutralization produces 1 mole of H 2 O 1\text{ mole of } H_2O 1 mole of H 2 O and ≈ 13,700 calories \approx 13{,}700\text{ calories} ≈ 13 , 700 calories ( ≈ 57 kJ \approx 57\text{ kJ} ≈ 57 kJ ) of heat per mole of C O 2 CO_2 C O 2 absorbed. A warm canister ( 45 − 55 ° C 45-55°\text{C} 45 − 55° C ) confirms active, functional absorption.
Exhaustion Indicator: Ethyl violet dye is incorporated into the granules. Under alkaline conditions (pH > 10.3), ethyl violet is completely colorless. As absorption exhausts the hydroxyl ions and accumulation of carbonic acid lowers pH \text{pH} pH below 10.3 10.3 10.3 , ethyl violet turns deep purple/violet .
Indicator Regeneration Trap: Exhausted soda lime left overnight can temporarily revert from purple to white as unreacted base from the center of granules diffuses slowly to the surface. However, upon re-exposure to C O 2 CO_2 C O 2 , it turns purple again within minutes.
Toxic Degradation Hazards: Compound A and Carbon Monoxide
When volatile halogenated anaesthetics interact with strong alkaline bases ( K O H KOH K O H and N a O H NaOH N a O H ) in carbon dioxide absorbents, dangerous degradation reactions can occur.
1. Compound A Formation (Sevoflurane)
Sevoflurane undergoes base-catalyzed dehydrofluorination when exposed to strong-base absorbents ( K O H > N a O H KOH > NaOH K O H > N a O H ), forming Compound A (fluoromethyl-2,2-difluoro-1-[trifluoromethyl]vinyl ether).
Toxicity: Nephrotoxic in Wistar rats, causing proximal renal tubular necrosis (toxic threshold ≈ 150 − 300 ppm ⋅ hours \approx 150-300\text{ ppm}\cdot\text{hours} ≈ 150 − 300 ppm ⋅ hours ). Although human clinical nephrotoxicity remains controversial, clinical guidelines mandate caution.
Conditions Favoring Compound A Production:
Very low fresh gas flows ( < 1 − 2 L/min <1-2\text{ L/min} < 1 − 2 L/min , allowing accumulation in the circle)
- High concentrations of sevoflurane
- Warm absorbent temperatures
- Dry, desiccated absorbent
- Absorbents containing high concentrations of K O H KOH K O H or N a O H NaOH N a O H
Clinical Prevention: The US product label states that fresh gas flows below 1 L/min 1\text{ L/min} 1 L/min are not recommended and that flows of 1 1 1 to < 2 L/min <2\text{ L/min} < 2 L/min should not exceed 2 MAC-hours 2\text{ MAC-hours} 2 MAC-hours ; many European labels permit lower flows, so follow local product information. Absorbents without strong bases minimise production.
2. Carbon Monoxide ( C O CO CO ) Production
Volatile anaesthetics containing a difluoromethoxy group ( − OCHF 2 -\text{OCHF}_2 − OCHF 2 ) react with completely desiccated strong-base absorbents ( K O H ≫ N a O H KOH \gg NaOH K O H ≫ N a O H ) to produce lethal concentrations of Carbon Monoxide ( C O CO CO ) .
Magnitude of Production: Desflurane ≫ \gg ≫ Enflurane > > > Isoflurane ≫ \gg ≫ Halothane ≈ \approx ≈ Sevoflurane .
(Desflurane produces the greatest quantities of C O CO CO by a massive margin).
Clinical Impact: Inhaled C O CO CO binds avidly to hemoglobin (affinity > 200 >200 > 200 times higher than O 2 O_2 O 2 ), generating dangerous carboxyhemoglobinemia ( C O H b > 30 % COHb > 30\% CO H b > 30% ), shifting the oxyhemoglobin dissociation curve to the left and causing severe tissue hypoxia.
The "Monday Morning Phenomenon": If high fresh gas flow is left running through an anaesthetic machine over a weekend, dry gas desiccates the soda lime. The first patient on Monday morning receiving desflurane suffers acute C O CO CO poisoning.
Modern Prevention: Transition to calcium hydroxide-only absorbents (such as Amsorb Plus , which contains C a ( O H ) 2 Ca(OH)_2 C a ( O H ) 2 and C a C l 2 CaCl_2 C a C l 2 , with zero K O H KOH K O H and zero N a O H NaOH N a O H ). These absorbents do not produce Compound A or Carbon Monoxide, even when completely dry.
Vaporizer Engineering: Variable-Bypass vs. Heated-Pressurized (Tec 6)
Vaporizers transform liquid volatile anaesthetics into calibrated, predictable vapor concentrations.
Physical Properties of Volatile Anaesthetics at 20°C
Volatile Agent Boiling Point at 1 atm 1\text{ atm} 1 atm Saturated Vapour Pressure ( S V P SVP S V P ) at 20 ° C 20°\text{C} 20° C MAC in 100 % O 2 100\%\text{ } O_2 100% O 2 (40 yo)
Sevoflurane 58.5 ° C 58.5°\text{C} 58.5° C 21 kPa 21\text{ kPa} 21 kPa ( 157 mmHg 157\text{ mmHg} 157 mmHg ) 2.0 % 2.0\% 2.0%
Isoflurane 48.5 ° C 48.5°\text{C} 48.5° C 32 kPa 32\text{ kPa} 32 kPa ( 238 mmHg 238\text{ mmHg} 238 mmHg ) 1.15 % 1.15\% 1.15%
Desflurane 22.8 ° C 22.8°\text{C} 22.8° C 88.5 kPa 88.5\text{ kPa} 88.5 kPa ( 664 mmHg 664\text{ mmHg} 664 mmHg ) 6.0 % 6.0\% 6.0%
Variable-Bypass (Plenum) Vaporizers (Tec 4, Tec 5, Tec 7, Dräger Vapor 2000)
Mechanism: Fresh gas entering the vaporizer divides into two streams:
Bypass Stream: The majority ( > 80 % >80\% > 80% ) passes straight through the bypass channel without contacting liquid agent.
Vaporizing Chamber Stream: A smaller fraction enters the chamber, passing over wicks and baffles that ensure 100 % 100\% 100% saturated vapour equilibrium ( S V P SVP S V P ).
The two streams recombine at the outlet. The concentration dial adjusts a precision rotary valve that alters the splitting ratio .
Temperature Compensation: Evaporation consumes latent heat of vaporization, causing the liquid to cool and lowering its S V P SVP S V P . To prevent output drop, a bimetallic strip (two metals with differing thermal expansion coefficients bonded together) or a thermal expansion cone bends as temperature drops. This automatically widens the vaporizing chamber orifice, increasing the fraction of gas diverted through the chamber to maintain a constant output concentration across operating temperatures ( 15 − 35 ° C 15-35°\text{C} 15 − 35° C ).
Flow and Pressure Compensation: Wicks maintain saturation at flows from 0.25 0.25 0.25 to 15 L/min 15\text{ L/min} 15 L/min . Internal baffles prevent liquid splashing into the bypass stream during transport. Keyed filler systems prevent filling with the wrong agent.
Heated-Pressurized Vaporizer (Tec 6 for Desflurane)
The Desflurane Challenge: Desflurane has a boiling point of 22.8 ° C 22.8°\text{C} 22.8° C (virtually ambient room temperature) and an extremely high S V P SVP S V P of 88.5 kPa 88.5\text{ kPa} 88.5 kPa ( 664 mmHg 664\text{ mmHg} 664 mmHg ) at 20 ° C 20°\text{C} 20° C . In a variable-bypass vaporizer on a warm day, desflurane would boil uncontrollably, resulting in massive, lethal surges in delivered concentration.
Tec 6 Design:
The vaporizer is an electrically heated, pressurized, measured-flow injector.
It is thermostatically heated to 39 ° C 39°\text{C} 39° C , well above desflurane's boiling point, generating a stable saturated vapour pressure of approximately 200 kPa 200\text{ kPa} 200 kPa ( 2 bar 2\text{ bar} 2 bar / 1500 mmHg 1500\text{ mmHg} 1500 mmHg ) .
Pure desflurane vapour is metered directly into the fresh gas stream through a variable resistance valve regulated by the concentration dial and an electronic differential pressure sensor matching fresh gas flow rate.
Electrical Requirement: Requires continuous mains electricity; incorporates battery backup for alarms.
The Altitude Effect on Vaporizers
Critical Distinction: Clinical depth of anaesthesia is governed by the partial pressure of volatile agent in the brain, NOT by volume percentage ( P agent = Vol % × P barometric P_{\text{agent}} = \text{Vol}\% \times P_{\text{barometric}} P agent = Vol % × P barometric ).
Variable-Bypass Vaporizers at Altitude: At high altitude (low barometric pressure), liquid volatile agent evaporates more readily, increasing the delivered volume percentage. However, because ambient barometric pressure is lower, the delivered partial pressure remains virtually unchanged . Thus, variable-bypass vaporizers require no dial adjustment at altitude .
Tec 6 Vaporizer at Altitude: The Tec 6 meters pure vapour to deliver a constant volume percentage ( V o l % Vol\% V o l % ), regardless of barometric pressure! Because barometric pressure ( P barometric P_{\text{barometric}} P barometric ) drops at altitude, the delivered partial pressure decreases significantly , risking intraoperative awareness.
Dial Correction Formula for Tec 6 at Altitude: Required Dial Setting = Desired Sea-Level Dial Setting × 760 mmHg P barometric ( mmHg ) \text{Required Dial Setting} = \frac{\text{Desired Sea-Level Dial Setting} \times 760\text{ mmHg}}{P_{\text{barometric}} (\text{mmHg})} Required Dial Setting = P barometric ( mmHg ) Desired Sea-Level Dial Setting × 760 mmHg Example: At an altitude of 2500 m 2500\text{ m} 2500 m ( P barometric ≈ 570 mmHg P_{\text{barometric}} \approx 570\text{ mmHg} P barometric ≈ 570 mmHg ), to deliver a clinical depth equivalent to 6 % 6\% 6% desflurane at sea level, the dial must be set to 6 × 760 570 = 8.0 % \frac{6 \times 760}{570} = 8.0\% 570 6 × 760 = 8.0% .
Anaesthetic Gas Scavenging Systems (AGSS)
Anaesthetic Gas Scavenging Systems (AGSS) capture and remove Waste Anaesthetic Gases (WAGs) discharged from breathing systems (APL valves and ventilator relief valves) to protect healthcare personnel from chronic exposure risks.
Occupational Standards: NIOSH limits atmospheric exposure to < 25 ppm <25\text{ ppm} < 25 ppm for nitrous oxide and < 2 ppm <2\text{ ppm} < 2 ppm for halogenated agents ( < 0.5 ppm <0.5\text{ ppm} < 0.5 ppm when used with N 2 O N_2O N 2 O ).
The Four Components of an AGSS
Collecting System: Shrouds enclosing the APL valve and ventilator exhaust port. Mandates a 30 mm 30\text{ mm} 30 mm conical connector (different from the 22 mm 22\text{ mm} 22 mm breathing circuit and 15 mm 15\text{ mm} 15 mm airway connectors) to physically prevent accidental connection of scavenging lines to the patient breathing circuit.
Transfer System: Tubing that routes collected gas to the receiving block.
Receiving System (Reservoir Block): Accommodates flow surges from exhalation.
Open Systems: Contain ports open to atmospheric air. Ambient air is entrained if suction exceeds gas production; gas spills out if suction fails. Requires no relief valves and cannot transmit positive or negative pressures to the patient.
Closed Systems: Require spring-loaded safety relief valves: a positive-pressure relief valve ( + 5 cmH 2 O +5\text{ cmH}_2\text{O} + 5 cmH 2 O ) to prevent circuit barotrauma if suction fails, and a negative-pressure relief valve ( − 0.5 cmH 2 O -0.5\text{ cmH}_2\text{O} − 0.5 cmH 2 O ) to prevent subatmospheric suction from evacuating gas from the patient's lungs.
Disposal System:
Active Disposal: Dedicated vacuum pump generating extraction flows of 75 − 130 L/min 75-130\text{ L/min} 75 − 130 L/min to an external roof vent.
Passive Disposal: Gas flows down a wide-bore hose venting through an external hospital wall via natural pressure gradients.